Nagrestipen

Nagrestipen (ECI 301), a variant of human MIP-1α, is a research compound studied for its antitumor properties. It is utilized in preclinical cancer research to investigate mechanisms against primary tumors and metastasis, including in radiation oncology contexts, through both in vitro and in vivo experimental models.